中外医疗2024,Vol.43Issue(3) :120-123.DOI:10.16662/j.cnki.1674-0742.2024.03.120

吡非尼酮联合乙酰半胱氨酸治疗特发性肺间质纤维化的疗效评价

Efficacy Evaluation of Pirfenidone Combined with Acetylcysteine in the Treatment of Idiopathic Pulmonary Interstitial Fibrosis

刘贞祥 王军 崔晓靖
中外医疗2024,Vol.43Issue(3) :120-123.DOI:10.16662/j.cnki.1674-0742.2024.03.120

吡非尼酮联合乙酰半胱氨酸治疗特发性肺间质纤维化的疗效评价

Efficacy Evaluation of Pirfenidone Combined with Acetylcysteine in the Treatment of Idiopathic Pulmonary Interstitial Fibrosis

刘贞祥 1王军 1崔晓靖1
扫码查看

作者信息

  • 1. 寿光市中医医院肺病科,山东潍坊 262700
  • 折叠

摘要

目的 探究吡非尼酮联合乙酰半胱氨酸治疗特发性肺间质纤维化的疗效.方法 回顾性选取2018年1月—2023年1月寿光市中医医院100例特发性肺间质纤维化患者的临床资料,按照用药方案不同分为两组,每组50例.对照组实施吡非尼酮治疗,观察组实施吡非尼酮联合乙酰半胱氨酸治疗.比较两组患者治疗效果.结果 观察组治疗有效率(96.00%)高于对照组的80.00%,差异有统计学意义(χ2=6.060,P<0.05).观察组肺部功能指标水平明显高于对照组,差异有统计学意义(P<0.05).观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05).观察组肺纤维化指标水平明显低于对照组,差异有统计学意义(P<0.05).结论 吡非尼酮、乙酰半胱氨酸联合的方法治疗特发性肺间质纤维化患者,可改善患者临床症状,显著提升治疗效果.

Abstract

Objective To explore the therapeutic effect of pirfenidone combined with acetylcysteine on idiopathic pul-monary interstitial fibrosis.Methods Clinical data of 100 patients with idiopathic pulmonary interstitial fibrosis in Shouguang Hospital of Traditional Chinese Medicine from January 2018 to January 2023 were retrospectively selected and divided into two groups according to different medication regimens,with 50 cases in each group.The control group was treated with pirfenidone,and the observation group was treated with pirfenidone combined with acetylcyste-ine.The therapeutic effect of the two groups was compared.Results The effective rate of treatment in observation group 96.00%was higher than that in control group(80.00%),the difference was statistically significant(χ2=6.060,P<0.05).The level of lung function indexes in the observation group was significantly higher than that in the control group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions in observation group was lower than that in control group,and the difference was statistically significant(P<0.05).The level of pulmonary fibrosis in-dexes in the observation group was significantly lower than that in the control group,and the difference was statisti-cally significant(P<0.05).Conclusion The combination of pirfenidone and acetylcysteine can improve the clinical symptoms of patients with idiopathic pulmonary interstitial fibrosis,and the therapeutic effect has been significantly improved.

关键词

吡非尼酮/乙酰半胱氨酸/特发性/肺间质纤维化

Key words

Pirfenidone/Acetylcysteine/Idiopathic/Pulmonary interstitial fibrosis

引用本文复制引用

出版年

2024
中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
浏览量1
参考文献量19
段落导航相关论文